Hib vaccine - PT Bio Farma

Drug Profile

Hib vaccine - PT Bio Farma

Alternative Names: Hib/PRP-T vaccine - PT Bio Farma

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PT Bio Farma
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Haemophilus infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Haemophilus-infections(Prevention, In volunteers) in Indonesia (Parenteral, Injection)
  • 31 Dec 2010 PT Bio Farma completes a phase I trial in Healthy volunteers in Indonesia (NCT01977170)
  • 30 Nov 2010 Phase-I clinical trials in Haemophilus infections (prevention, in volunteers) in Indonesia (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top